CAS 87862-25-7
:m-iodo-benzylguanidine sulfate
Description:
m-Iodo-benzylguanidine sulfate, commonly referred to as MIBG, is a chemical compound that serves primarily as a radiopharmaceutical and is utilized in medical imaging and treatment, particularly in neuroendocrine tumors. It is characterized by its structure, which includes a benzyl group substituted with an iodine atom at the meta position relative to the guanidine moiety. This substitution enhances its affinity for certain receptors, particularly the norepinephrine transporter, making it useful in targeting neuroblastoma and other tumors that express these receptors. The sulfate component contributes to its solubility in aqueous solutions, facilitating its use in clinical settings. MIBG is typically administered in a radiolabeled form, allowing for both diagnostic imaging via scintigraphy and therapeutic applications through targeted radiation. Safety and efficacy are paramount in its use, necessitating careful handling and administration by healthcare professionals. Overall, m-iodo-benzylguanidine sulfate is a significant compound in the field of nuclear medicine, combining unique chemical properties with practical applications in oncology.
- (3-Iodobenzyl)guanidine hemisulfate
- MIBG hemisulfate
- meta-Iodobenzylguanidine hemisulfate
- Guanidine, [(3-iodophenyl)methyl]-, sulfate (2:1)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Iobenguane sulfate
CAS:Iobenguane sulfate is used in radioiodinated form to diagnose and treat adrenergic tumors.Formula:C8H10IN3H2O4SPurity:99.04%Color and Shape:SolidMolecular weight:324.12Guanidine, [(3-iodophenyl)methyl]-, sulfate (2:1)
CAS:Formula:C16H22I2N6O4SPurity:98%Color and Shape:SolidMolecular weight:648.25763-Iodobenzylguanidine hemisulphate [m-IBG]
CAS:<p>3-Iodobenzylguanidine hemisulphate [m-IBG]</p>Purity:97%Molecular weight:648.26g/molm-Iodobenzylguanidine Hemisulfate
CAS:Controlled ProductFormula:C8H10IN3·H2O4SColor and Shape:NeatMolecular weight:648.26m-Iodobenzylguanidine hemisulfate
CAS:<p>m-Iodobenzylguanidine hemisulfate (MBG) is an anti-cancer compound that inhibits the uptake of fatty acids by the mitochondria, leading to cell death. MBG has been shown to have a high affinity for cardiac fatty acid binding protein and low affinity for human serum albumin. MBG has been used in the diagnosis and treatment of infectious diseases, autoimmune diseases, and as a radiation sensitizer. MBG is also used in diagnostic radiology as a contrast agent for myocardial perfusion imaging. The uptake of MBG is dependent on the presence of specific receptors, which are located on the cell membrane. These receptors are called carboxy terminal (CT). It has been shown that CT-1 is involved in the uptake of MBG into cells and that CT-2 may be involved in its metabolism.</p>Formula:C8H10IN3H2SO4Purity:Min. 95%







